Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Yuichiro Kanno"'
Publikováno v:
Pharmacological Research - Modern Chinese Medicine, Vol 3, Iss , Pp 100107- (2022)
Gegen qinlian decoction (GGQLD) is a Traditional Chinese Medicine formula comprising four herbal medicines. It is commonly used to treat bacterial dysentery in the past. Modern research has repositioned this decoction and applied it to treat type 2 d
Externí odkaz:
https://doaj.org/article/2d1be630afb94b028973c2d708eca27f
Autor:
Yuichiro Kanno, Taichi Kusakabe, Nao Saito, Shoko Kikkawa, Keisuke Takahashi, Isao Azumaya, Kiyomitsu Nemoto, Keisuke Kato
Publikováno v:
Molbank, Vol 2020, Iss 2, p M1125 (2020)
The palladium catalyzed carbonylation of 1 using the chiral ligand L1 afforded 2 in a highly diastereoselective manner. The stereochemistry of the major diastereomer 2a was determined by X-ray crystallographic analysis. AR luciferase reporter assay s
Externí odkaz:
https://doaj.org/article/28105ca753dc48018fea17728ddf7f60
Autor:
Rong Shen, Taichi Kusakabe, Tomofumi Yatsu, Yuichiro Kanno, Keisuke Takahashi, Kiyomitsu Nemoto, Keisuke Kato
Publikováno v:
Molecules, Vol 21, Iss 9, p 1177 (2016)
An efficient PdII/Pd0-p-benzoquinone/hydroquinone-CuCl2/CuCl catalyst system was developed that uses environmentally friendly molecular oxygen as the terminal oxidant to catalyze the cyclization-carbonylation-cyclization coupling reaction (CCC-coupli
Externí odkaz:
https://doaj.org/article/55d3cd337e8043e6b2b03ce262d75dc6
Autor:
Takumi Sato, Ryota Shizu, Ryonosuke Baba, Akira Ooka, Takuomi Hosaka, Yuichiro Kanno, Kouichi Yoshinari
Publikováno v:
Biochemical Journal; 9/15/2024, Vol. 481 Issue 18, p1173-1186, 14p
Autor:
Naoya Yamashita, Kaho Kawai, Minami Yoshikawa, Mina Watabe, Yuichiro Kanno, Noriko Sanada, Ryoichi Kizu
Publikováno v:
Biochemical and Biophysical Research Communications. 639:29-35
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is activated by environmental contaminants such as dioxins and polycyclic aromatic hydrocarbons. Following ligand binding, AhR binds to xenobiotic responsive elements
Autor:
Naoya Yamashita1 nayamash@dwc.doshisha.ac.jp, Yuichiro Kanno2,3, Minami Yoshikawa1, Moeno Ozawa1, Noriko Sanada1, Kiyomitsu Nemoto2, Ryoichi Kizu1
Publikováno v:
Journal of Toxicological Sciences. 2021, Vol. 46 Issue 1, p25-29. 5p.
Autor:
Arisa Kase, Yuichiro Kanno, Ryoichi Kizu, Kiyomitsu Nemoto, Moeno Ozawa, Naoya Yamashita, Chiharu Taga, Arika Yoshizuka, Noriko Sanada
Publikováno v:
Biochemical and Biophysical Research Communications. 570:131-136
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates various toxicological and biological functions. We reported previously that 3-methylcholanthrene (3MC), an exogenous AhR agonist, inhibited tumorsphere (mam
Publikováno v:
Journal of Natural Medicines. 76:110-118
Breast cancer is the most commonly diagnosed cancer among women worldwide. Despite a variety of drugs available for the treatment of patients with breast cancer, drug resistance remains a significant clinical problem. Therefore, there is an urgent ne
Autor:
Yuichiro Kanno, Nao Saito, Naoya Yamashita, Kazuki Ota, Ryota Shizu, Takuomi Hosaka, Kiyomitsu Nemoto, Kouichi Yoshinari
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12095
Cancer stem cells (CSCs) contribute to the drug resistance, recurrence, and metastasis of breast cancers. Recently, we demonstrated that HER2 overexpression increases mammosphere formation via the activation of aryl hydrocarbon receptor (AHR). In thi
Publikováno v:
Biologicalpharmaceutical bulletin. 45(6)
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity of dioxins and polycyclic aromatic hydrocarbons. Recent studies have suggested that AhR is involved in cancer immunity. In the present study, we